Akebia Therapeutics Inc logo

Akebia Therapeutics Inc

FRA:AX9 (USA)  
€ 1.26 (+0.56%) Sep 12
At Loss
Market Cap:
€ 275.02M ($ 304.68M)
Enterprise V:
€ 284.11M ($ 314.75M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Akebia Therapeutics Inc Valuation Measures